Claudia Gravekamp

2.6k citations
32 papers · 1.8k indexed · 1 hit paper · h-index 18
Topics
Cancer Research and Treatments (8 papers)Streptococcal Infections and Treatments (8 papers)Neonatal and Maternal Infections (8 papers)

In The Last Decade

Claudia Gravekamp

32 papers receiving 1.8k citations

Hit Papers

Tumour-targeting bacteria engineered to fight cancer20182026202020232018200400600

Peers

Claudia Gravekamp
Comparison fields: 5 of 100
  • Biotechnology 885
  • Biomedical Engineering 728
  • Molecular Biology 395
  • Immunology 352
  • Epidemiology 290
Replace Wilber Quispe‐Tintaya with:
Wilber Quispe‐Tintaya United States
André Catic United States
Fred R. Frankel United States
Royce A. Wilkinson United States
Alison A. McCormick United States
Alice Lebreton France
Judith Kandel United States
Miguel Álvaro‐Benito Germany
Bogdan Mateescu Switzerland
Joan M. Moehring United States
Claudia Gravekamp relative to Wilber Quispe‐Tintaya United States Wilber Quispe‐Tintaya's profile →
Citations per field
00.5×4.9×
Wilber Quispe‐Tintaya · 1×
Citations per year

Countries citing papers authored by Claudia Gravekamp

Since Specialization
Citations

This map shows the geographic impact of Claudia Gravekamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Gravekamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Gravekamp more than expected).

Fields of papers citing papers by Claudia Gravekamp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Gravekamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Gravekamp. The network helps show where Claudia Gravekamp may publish in the future.

Co-authorship network of co-authors of Claudia Gravekamp

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Gravekamp. A scholar is included among the top collaborators of Claudia Gravekamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Gravekamp. Claudia Gravekamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 17
3 38
4
Tumour-targeting bacteria engineered to fight cancerbreakdown →
608
5 1
6 40
7 17
8 165
9 113
10 28
11 19
12 164
13 59
14 24
15 3
16 2
17 64
18
Wederom een geval van hantavirusinfectie in Nederland.
1
19 14
20 8

About Claudia Gravekamp

Claudia Gravekamp is a scholar working on Biotechnology, Aging and Oncology, having authored 32 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Research and Treatments (8 papers), Streptococcal Infections and Treatments (8 papers) and Neonatal and Maternal Infections (8 papers). The work is most often cited by research in Biotechnology (885 citations), Immunology (352 citations) and Biomedical Engineering (728 citations). Claudia Gravekamp has collaborated with scholars based in United States, Netherlands and Belgium. Frequent co-authors include Ke Liu, David Bermudes, Shibin Zhou, Dinesh Chandra, Lawrence C. Madoff, Yvonne Paterson, Wilber Quispe‐Tintaya, Arthee Jahangir, Sun Hee Kim and Francisco Castro. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature reviews. Cancer and Nature Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026